TILAVONEMAB
UNII MY9Z7GDJ8J

Substance Identification & Data

This profile provides standardized clinical and technical data for Tilavonemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MY9Z7GDJ8J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2096513-89-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MY9Z7GDJ8J

CAS Registry Number

2096513-89-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TILAVONEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174727

National Cancer Institute reference terminology for clinical and research data.

INN ID

10957

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-128

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tilavonemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TILAVONEMAB

Common Names & Synonyms

TILAVONEMAB [INN]

TILAVONEMAB [USAN]

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(HUMAN TAU PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1649264 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1649264 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MAPT (MICROTUBULE-ASSOCIATED PROTEIN TAU, TAU)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-442) (VH (MUS MUSCULUS IGHV6-3*01 (91.9%)-(IGHD)-IGHJ4*01 (92.3%)/HOMO SAPIENS IGHV3-7*01 (71.4%)-(IGHD)-IGHJ4*01 (92.3%)) (8.10.6) (1-115)-HOMO SAPIENS IGHG4*01 (CH1 (116-213), HINGE S10>P (223) (214-225), CH2 (226-335), CH3 (336-440), CHS (441-442)) (115-442)), (129-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-7*01 (90.9%)-IGKJ2*03 (90.9%)/HOMO SAPIENS IGKV4-1*01 (69.3%)-IGKJ2*01 (100%)) (10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218'))DIMER (221-221'':224-224'')-BISDISULFIDE

SYS